Altered GCR response has been associated with the pathogenesis of several diseases, such as altered susceptibility to sporadic breast-cancer among Caucasian women [22], metabolic syndrome [23], cardiovascular disease [24], rheumatoid arthritis [25], and depression [26]. Here, NR3C1 is linked to breast cancer.